# HealthyTide

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/healthytide

- Industry: Biotechnology
- Headquarters: Hangzhou, China
- Website: www.healthytide.cn
- Latest round: Angel (Jul 29, 2021)
- Investors on record: 1

## About

Based in Hangzhou, China and founded in 2021, HealthyTide operates as a peptide-based innovative drug developer that has built a peptide-based innovative drug development platform. HealthyTide has cooperated with some universities and institutes, such as Sun Yat-Sen University, Tsinghua University, China Institute of Atomic Energy, and Hangzhou Institute for Advanced Study, UCAS. Some certificates, such as National Science and Technology SMEs, and Zhejiang Science and Technology SMEs, have been granted to the company. The chairman of the board, is Jian Gao is a postdoctoral fellow at the University of Basel, Switzerland.

HealthyTide is engaged in the research and development of conventional therapeutic peptide drugs, functional peptide compounds, PDC peptide coupled drugs, peptide nucleotide coupled diagnostic and therapeutic drugs, and peptide coupled fluorescent tracer diagnostic drugs. The company's core technology R&D platform is composed of the core technology system for targeted peptide innovative molecular discovery and the platform for targeted peptide receptor-mediated radionuclide therapy (PRRT) innovative drug development. The technology and products can be used in areas including conventional therapeutic peptide drugs, functional peptide compounds, PDC peptide coupled drugs, and other areas.

## Funding rounds

- Angel, Jul 29, 2021 — Thunderstorm VC

## Investors

- Thunderstorm VC (https://capitalatlas.ai/funds/thunderstorm-vc) — Angel